Report Detail
Global Henagliflozin Proline Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4702031 |
- 01 June, 2026 |
- Global |
- 80 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Henagliflozin Proline Tablets market size was valued at US$ 143 million in 2025 and is forecast to a readjusted size of US$ 484 million by 2032 with a CAGR of 14.6% during review period.
Henagliflozin Proline Tablets are a sodium-glucose cotransporter 2 (SGLT-2) inhibitor. By inhibiting the reabsorption of glucose in the kidneys, they allow excess sugar to be excreted directly in the urine, thereby lowering blood glucose levels. They are mainly used to improve glycemic control in patients with type 2 diabetes. Characterized by insulin-independent hypoglycemic effect, clear cardiovascular benefits, and positive regulatory effects on body weight and blood pressure, the drug can be used alone or in combination with other antidiabetic agents such as metformin. It is suitable for the daily management of type 2 diabetes in adults, providing a novel and well-tolerated oral hypoglycemic option for clinical practice.In 2025, global Henagliflozin Proline Tablets production reached approximately 120 million bottles.
As the first domestically developed oral SGLT-2 inhibitor for diabetes in China, Henagliflozin Proline Tablets have grown amid the expanding global and domestic demand for diabetes treatment and the rapid rise of the SGLT-2 inhibitor class. At present, SGLT-2 inhibitors have become core medications for the management of type 2 diabetes due to their unique insulin-independent mechanism, reliable glucose-lowering efficacy, and dual cardiorenal benefits. While the market is still dominated by international originator brands, domestic innovative drugs and generics are rapidly gaining share. Relying on its advantages as a local innovative product, support from medical insurance coverage, favorable safety profile, and compatibility in combination therapies, henagliflozin has achieved rapid penetration in the domestic market, with particularly strong growth in public medical institutions. Going forward, its market potential is expected to keep expanding as its indications are extended to include heart failure and chronic kidney disease, combined preparations are launched, and overseas layout progresses. Meanwhile, the product will face intense competition from international pharmaceutical giants, domestic generics, and new types of hypoglycemic agents. Overall, it is on a development path featured by breakthroughs of domestic innovation, indication-driven growth, and dual drivers of medical insurance and clinical value.
This report is a detailed and comprehensive analysis for global Henagliflozin Proline Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Henagliflozin Proline Tablets market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Henagliflozin Proline Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Henagliflozin Proline Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Henagliflozin Proline Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Henagliflozin Proline Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Henagliflozin Proline Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jiangsu Hengrui Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Henagliflozin Proline Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
5 mg
10 mg
Market segment by Combination Therapy
Henagliflozin Proline Tablets And Metformin
Henagliflozin Proline Tablets And Insulin
Market segment by Sales Channels
Hospital
Retail
Online
Market segment by Application
Type 2 Diabetes Mellitus
Heart Failure
Chronic Kidney Disease
Others
Major players covered
Jiangsu Hengrui Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Henagliflozin Proline Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Henagliflozin Proline Tablets, with price, sales quantity, revenue, and global market share of Henagliflozin Proline Tablets from 2021 to 2026.
Chapter 3, the Henagliflozin Proline Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Henagliflozin Proline Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Henagliflozin Proline Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Henagliflozin Proline Tablets.
Chapter 14 and 15, to describe Henagliflozin Proline Tablets sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Henagliflozin Proline Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 5 mg
- 1.3.3 10 mg
- 1.4 Market Analysis by Combination Therapy
- 1.4.1 Overview: Global Henagliflozin Proline Tablets Consumption Value by Combination Therapy: 2021 Versus 2025 Versus 2032
- 1.4.2 Henagliflozin Proline Tablets And Metformin
- 1.4.3 Henagliflozin Proline Tablets And Insulin
- 1.5 Market Analysis by Sales Channels
- 1.5.1 Overview: Global Henagliflozin Proline Tablets Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
- 1.5.2 Hospital
- 1.5.3 Retail
- 1.5.4 Online
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global Henagliflozin Proline Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Type 2 Diabetes Mellitus
- 1.6.3 Heart Failure
- 1.6.4 Chronic Kidney Disease
- 1.6.5 Others
- 1.7 Global Henagliflozin Proline Tablets Market Size & Forecast
- 1.7.1 Global Henagliflozin Proline Tablets Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Henagliflozin Proline Tablets Sales Quantity (2021-2032)
- 1.7.3 Global Henagliflozin Proline Tablets Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Jiangsu Hengrui Pharmaceutical
- 2.1.1 Jiangsu Hengrui Pharmaceutical Details
- 2.1.2 Jiangsu Hengrui Pharmaceutical Major Business
- 2.1.3 Jiangsu Hengrui Pharmaceutical Henagliflozin Proline Tablets Product and Services
- 2.1.4 Jiangsu Hengrui Pharmaceutical Henagliflozin Proline Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Jiangsu Hengrui Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Henagliflozin Proline Tablets by Manufacturer
- 3.1 Global Henagliflozin Proline Tablets Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Henagliflozin Proline Tablets Revenue by Manufacturer (2021-2026)
- 3.3 Global Henagliflozin Proline Tablets Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Henagliflozin Proline Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Henagliflozin Proline Tablets Manufacturer Market Share in 2025
- 3.4.3 Top 6 Henagliflozin Proline Tablets Manufacturer Market Share in 2025
- 3.5 Henagliflozin Proline Tablets Market: Overall Company Footprint Analysis
- 3.5.1 Henagliflozin Proline Tablets Market: Region Footprint
- 3.5.2 Henagliflozin Proline Tablets Market: Company Product Type Footprint
- 3.5.3 Henagliflozin Proline Tablets Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Henagliflozin Proline Tablets Market Size by Region
- 4.1.1 Global Henagliflozin Proline Tablets Sales Quantity by Region (2021-2032)
- 4.1.2 Global Henagliflozin Proline Tablets Consumption Value by Region (2021-2032)
- 4.1.3 Global Henagliflozin Proline Tablets Average Price by Region (2021-2032)
- 4.2 North America Henagliflozin Proline Tablets Consumption Value (2021-2032)
- 4.3 Europe Henagliflozin Proline Tablets Consumption Value (2021-2032)
- 4.4 Asia-Pacific Henagliflozin Proline Tablets Consumption Value (2021-2032)
- 4.5 South America Henagliflozin Proline Tablets Consumption Value (2021-2032)
- 4.6 Middle East & Africa Henagliflozin Proline Tablets Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Henagliflozin Proline Tablets Sales Quantity by Type (2021-2032)
- 5.2 Global Henagliflozin Proline Tablets Consumption Value by Type (2021-2032)
- 5.3 Global Henagliflozin Proline Tablets Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Henagliflozin Proline Tablets Sales Quantity by Application (2021-2032)
- 6.2 Global Henagliflozin Proline Tablets Consumption Value by Application (2021-2032)
- 6.3 Global Henagliflozin Proline Tablets Average Price by Application (2021-2032)
7 North America
- 7.1 North America Henagliflozin Proline Tablets Sales Quantity by Type (2021-2032)
- 7.2 North America Henagliflozin Proline Tablets Sales Quantity by Application (2021-2032)
- 7.3 North America Henagliflozin Proline Tablets Market Size by Country
- 7.3.1 North America Henagliflozin Proline Tablets Sales Quantity by Country (2021-2032)
- 7.3.2 North America Henagliflozin Proline Tablets Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Henagliflozin Proline Tablets Sales Quantity by Type (2021-2032)
- 8.2 Europe Henagliflozin Proline Tablets Sales Quantity by Application (2021-2032)
- 8.3 Europe Henagliflozin Proline Tablets Market Size by Country
- 8.3.1 Europe Henagliflozin Proline Tablets Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Henagliflozin Proline Tablets Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Henagliflozin Proline Tablets Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Henagliflozin Proline Tablets Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Henagliflozin Proline Tablets Market Size by Region
- 9.3.1 Asia-Pacific Henagliflozin Proline Tablets Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Henagliflozin Proline Tablets Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Henagliflozin Proline Tablets Sales Quantity by Type (2021-2032)
- 10.2 South America Henagliflozin Proline Tablets Sales Quantity by Application (2021-2032)
- 10.3 South America Henagliflozin Proline Tablets Market Size by Country
- 10.3.1 South America Henagliflozin Proline Tablets Sales Quantity by Country (2021-2032)
- 10.3.2 South America Henagliflozin Proline Tablets Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Henagliflozin Proline Tablets Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Henagliflozin Proline Tablets Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Henagliflozin Proline Tablets Market Size by Country
- 11.3.1 Middle East & Africa Henagliflozin Proline Tablets Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Henagliflozin Proline Tablets Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Henagliflozin Proline Tablets Market Drivers
- 12.2 Henagliflozin Proline Tablets Market Restraints
- 12.3 Henagliflozin Proline Tablets Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Henagliflozin Proline Tablets and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Henagliflozin Proline Tablets
- 13.3 Henagliflozin Proline Tablets Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Henagliflozin Proline Tablets Typical Distributors
- 14.3 Henagliflozin Proline Tablets Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Henagliflozin Proline Tablets. Industry analysis & Market Report on Henagliflozin Proline Tablets is a syndicated market report, published as Global Henagliflozin Proline Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Henagliflozin Proline Tablets market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
